SCIENTURE HOLDINGS, INC. Number of Reportable Segments
SCIENTURE HOLDINGS, INC. (SCNX) reported Number of Reportable Segments of 1 Integer for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-05-15
- SCIENTURE HOLDINGS, INC. number of reportable segments for the quarter ending 2026-03-31 was 1.00 Integer.
- SCIENTURE HOLDINGS, INC. number of reportable segments for fiscal 2025 was 1.00 Integer.
| Period end | Number of Reportable Segments 3 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-03-31 | 1.00 Integer 10-Q · filed 2026-05-15 | |
| 2025-12-31 | 1.00 Integer 10-K · filed 2026-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |